Implications for Strategy and Industrial Change
Edited by Ken Green, Marcela Miozzo and Paul Dewick
Chapter 8: New Science and Old Industries: Adoption of Biotechnology in European Food Companies
8. Discontinuities and distributed innovation: the case of biotechnology in food processing Finn Valentin and Rasmus Lund Jensen1 INTRODUCTION 1. Through the 20th century the life sciences became an important source of innovation and economic development, and that importance is expected to grow further over the next decades. At the same time, its discovery process and further linkages to technologies and applications have come to depend on complicated (inter)organizational forms which in turn are quite sensitive to institutional inﬂuences and regulation (Cockburn et al., 1999). Consequently, interdependencies between these organizational forms and the economic performance of life science-based industries have attracted interest since the onset of the biotech revolution. This interest increased as the US model for biotech competitiveness through the 1990s became idealized as the model against which other countries could be benchmarked. But this idealization needs scrutiny. We need to better understand if the success of the US model is speciﬁc to particular areas – or stages – of biotechnology. Will the infusion of biotechnology into agriculture and foods require other models? And will diﬀerent organizational and institutional forms prove equally successful as other countries move biotechnology into new ﬁelds of application. To learn from the US experience we must see it in comparative perspective (Chesbrough, 2001; Lynskey, 2001). Everywhere biotechnologies induce distributed forms of innovations (Coombs and Metcalfe, 2000), involving networks of collaboration between large ﬁrms and outside partners (Liebeskind et al., 1996; Powell, 1998; Sharp and Senker, 1999). The formation of more than a...
You are not authenticated to view the full text of this chapter or article.